HUM
Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Insiders: neutral. Moteurs : Congrès, fondamentaux. Initiés : neutre.
Research, not advice.
À propos
Humana Inc.
- Nom
- Humana Inc.
- Secteur
- Healthcare
- Industrie
- Medical - Healthcare Plans
- Bourse
- NYSE
- Capitalisation
- $50.8B
- Employés
- 67,060
- PDG
- James A. Rechtin
- Site web
- https://www.humana.com
- Marché
- ALHCCICNCCVSELVMOH
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Decouvert par les declarations du Congres
- Insiders
- —
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
—
Avg sell (VWAP, 90d window) —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- —
- Last synced
-
2026-10-06 10:56:08
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
No Form 4 filings for this company in this window.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-04-10 | Michael T. McCaul | Purchase | $1,001 - $15,000 |
| 2026-02-10 | Julia Letlow | Sale | $1,001 - $15,000 |
| 2026-01-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-11-12 | Gilbert Ray Cisneros | Sale (Full) | $1,001 - $15,000 |
| 2025-11-04 | Michael T. McCaul | Sale | $15,001 - $50,000 |
| 2025-10-31 | Lisa C. McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-10-30 | Lisa C. McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-10-30 | Lisa C. McClain | Purchase | $1,001 - $15,000 |
| 2025-09-25 | Lisa C. McClain | Purchase | $1,001 - $15,000 |
| 2025-08-08 | Julia Letlow | Purchase | $1,001 - $15,000 |
| 2025-08-05 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2025-07-25 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-06-24 | Lisa C. McClain | Purchase | $1,001 - $15,000 |
| 2025-05-30 | Gilbert Ray Cisneros | Sale | $1,001 - $15,000 |
| 2025-05-28 | Michael T. McCaul | Purchase | $15,001 - $50,000 |
| 2025-05-19 | Michael T. McCaul | Purchase | $50,001 - $100,000 |
| 2025-05-19 | Michael T. McCaul | Purchase | $15,001 - $50,000 |
| 2025-05-15 | Robert P. Bresnahan | Sale (Full) | $1,001 - $15,000 |
| 2025-04-29 | Gilbert Ray Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 2025-04-10 | Michael T. McCaul | Purchase | $100,001 - $250,000 |
| 2025-02-26 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2025-02-25 | Robert P. Bresnahan | Purchase | $1,001 - $15,000 |
| 2025-01-23 | Michael T. McCaul | Purchase | $100,001 - $250,000 |
| 2025-01-15 | Michael T. McCaul | Purchase | $15,001 - $50,000 |
| 2025-01-09 | Michael T. McCaul | Sale | $50,001 - $100,000 |
| 2024-11-19 | Michael T. McCaul | Sale | $50,001 - $100,000 |
| 2024-11-15 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-10-02 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-10-02 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-10-02 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-09-04 | John James | Sale (Full) | $1,001 - $15,000 |
| 2024-05-22 | Michael T. McCaul | Purchase | $50,001 - $100,000 |
| 2024-05-22 | Michael T. McCaul | Purchase | $50,001 - $100,000 |
| 2024-05-14 | Michael T. McCaul | Purchase | $50,001 - $100,000 |
| 2024-05-14 | Michael T. McCaul | Purchase | $50,001 - $100,000 |
| 2024-05-02 | Michael T. McCaul | Purchase | $15,001 - $50,000 |
| 2024-05-02 | Michael T. McCaul | Purchase | $15,001 - $50,000 |
| 2024-03-25 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-03-20 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-02-21 | Michael T. McCaul | Purchase | $100,001 - $250,000 |
| 2024-02-21 | Michael T. McCaul | Purchase | $50,001 - $100,000 |
| 2024-02-13 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-02-13 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-11-10 | John James | Purchase | $1,001 - $15,000 |
| 2023-11-03 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-10-26 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-09-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-08-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-06-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-06-26 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-06-21 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2023-05-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-05-19 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-04-20 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-04-12 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-04-12 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-02-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-01-30 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-01-11 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-01-11 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-12-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-10-21 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-20 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-20 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-13 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-09-15 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-07-14 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-05-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-02-17 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-02-14 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-02-09 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-01-21 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2021-06-15 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2021-06-14 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2021-03-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2021-02-11 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2021-02-11 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2021-01-28 | Peter Meijer | Sale (Full) | $1,001 - $15,000 |
| 2020-11-19 | Kenny Marchant | Purchase | $15,001 - $50,000 |
| 2020-11-19 | Kenny Marchant | Purchase | $15,001 - $50,000 |
| 2020-10-29 | John Yarmuth | Purchase | $1,001 - $15,000 |
| 2020-03-18 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2019-08-14 | Gilbert Ray Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 2018-12-17 | Virginia Ann Foxx | Sale (Full) | $50,001 - $100,000 |
| 2018-08-06 | Gary James Palmer | Purchase | $1,001 - $15,000 |
| 2018-07-31 | Gary James Palmer | Sale (Full) | $1,001 - $15,000 |
| 2018-02-14 | Josh S. Gottheimer | Sale (Full) | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Insiders: neutral. Moteurs : Congrès, fondamentaux. Initiés : neutre.
HUM presents a deeply concerning financial profile with net margins near 1%, a sub-1.0 current ratio, and an interest coverage ratio of only 2.3x, leaving virtually no margin of safety.
The first sentence of the analysis written for HUM on 2026-10-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Unavailable or mixed. No open-market purchase or sale value stored
- Congress Unavailable or mixed. 1 purchase disclosure year to date, a thin reading
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Pulls against a bullish reading. Current ratio 0.72 · operating margin 1.1%
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 14.5% | 14.6% | 17.0% | 18.5% | 17.3% | |
| Ebit Margin | 1.6% | 1.9% | 3.6% | 4.3% | 4.5% | |
| Ebitda Margin | 2.2% | 2.8% | 4.4% | 5.2% | 5.3% | |
| Operating Profit Margin | 1.1% | 1.4% | 3.1% | 3.8% | 4.1% | |
| Pretax Profit Margin | 1.1% | 1.4% | 3.1% | 3.8% | 4.1% | |
| Continuous Operations Profit Margin | 0.9% | 1.0% | 2.3% | 3.0% | 3.5% | |
| Net Profit Margin | 0.9% | 1.0% | 2.3% | 3.0% | 3.5% | |
| Bottom Line Profit Margin | 0.9% | 1.0% | 2.3% | 3.0% | 3.5% | |
| Current Ratio | 0.724 | 0.438 | 0.563 | 0.579 | 0.496 | |
| Quick Ratio | 0.724 | 0.438 | 0.563 | 0.579 | 0.496 | |
| Solvency Ratio | 0.065 | 0.073 | 0.111 | 0.129 | 0.127 | |
| Cash Ratio | 0.407 | 0.197 | 0.393 | 0.435 | 0.323 | |
| Price To Earnings Ratio | 25.950 | 25.346 | 22.788 | 23.072 | 20.354 | |
| Price To Earnings Growth Ratio | -18.555 | -0.505 | -2.398 | -8.912 | -1.934 | |
| Forward Price To Earnings Growth Ratio | -18.555 | -0.505 | -2.398 | -8.912 | -1.934 | |
| Price To Earnings Diluted Ratio | 26.029 | 25.422 | 22.890 | 23.197 | 20.461 | |
| Price To Earnings Diluted Growth Ratio | -18.555 | -0.507 | -2.430 | -8.913 | -1.962 | |
| Price To Book Ratio | 1.747 | 1.868 | 3.487 | 4.229 | 3.712 | |
| Price To Sales Ratio | 0.238 | 0.260 | 0.533 | 0.697 | 0.714 | |
| Price To Free Cash Flow Ratio | 82.272 | 12.794 | 19.048 | 18.768 | 64.884 | |
| Price To Operating Cash Flow Ratio | 33.498 | 10.314 | 14.244 | 14.116 | 26.390 | |
| Debt To Assets Ratio | 0.265 | 0.265 | 0.262 | 0.269 | 0.296 | |
| Debt To Equity Ratio | 0.733 | 0.749 | 0.754 | 0.768 | 0.822 | |
| Debt To Capital Ratio | 0.423 | 0.428 | 0.430 | 0.434 | 0.451 | |
| Long Term Debt To Capital Ratio | 0.412 | 0.405 | 0.386 | 0.371 | 0.396 | |
| Financial Leverage Ratio | 2.761 | 2.828 | 2.884 | 2.856 | 2.783 | |
| Working Capital Turnover Ratio | -28.262 | -20.402 | -21.048 | -18.252 | -19.752 | |
| Operating Cash Flow Ratio | 0.089 | 0.263 | 0.333 | 0.394 | 0.216 | |
| Operating Cash Flow Sales Ratio | 0.007 | 0.025 | 0.037 | 0.049 | 0.027 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.407 | 0.806 | 0.748 | 0.752 | 0.407 | |
| Debt Service Coverage Ratio | 3.403 | 2.053 | 1.850 | 1.520 | 1.612 | |
| Interest Coverage Ratio | 2.303 | 2.465 | 6.734 | 8.888 | 10.488 | |
| Short Term Operating Cash Flow Coverage Ratio | 6.140 | 4.097 | 2.470 | 2.027 | 1.058 | |
| Operating Cash Flow Coverage Ratio | 0.071 | 0.242 | 0.324 | 0.390 | 0.171 | |
| Capital Expenditure Coverage Ratio | 1.687 | 5.158 | 3.965 | 4.034 | 1.686 | |
| Dividend Paid And Capex Coverage Ratio | 0.944 | 2.948 | 2.774 | 3.000 | 1.334 | |
| Dividend Payout Ratio | 0.362 | 0.357 | 0.173 | 0.140 | 0.121 | |
| Enterprise Value Multiple | 13.614 | 12.482 | 13.590 | 14.853 | 15.595 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 14.5% | ▼-0.0% | ▼-1.8% |
| Ebit Margin | 1.6% | ▼-0.3% | ▼-1.6% |
| Ebitda Margin | 2.2% | ▼-0.5% | ▼-1.8% |
| Operating Profit Margin | 1.1% | ▼-0.3% | ▼-1.6% |
| Pretax Profit Margin | 1.1% | ▼-0.3% | ▼-1.6% |
| Continuous Operations Profit Margin | 0.9% | ▼-0.1% | ▼-1.2% |
| Net Profit Margin | 0.9% | ▼-0.1% | ▼-1.2% |
| Bottom Line Profit Margin | 0.9% | ▼-0.1% | ▼-1.2% |
| Current Ratio | 0.724 | ▲0.287 | ▲0.164 |
| Quick Ratio | 0.724 | ▲0.287 | ▲0.164 |
| Solvency Ratio | 0.065 | ▼-0.008 | ▼-0.036 |
| Cash Ratio | 0.407 | ▲0.210 | ▲0.056 |
| Price To Earnings Ratio | 25.950 | ▲0.605 | ▲2.449 |
| Price To Earnings Growth Ratio | -18.555 | ▼-18.049 | ▼-12.094 |
| Forward Price To Earnings Growth Ratio | -18.555 | ▼-18.049 | ▼-12.094 |
| Price To Earnings Diluted Ratio | 26.029 | ▲0.608 | ▲2.429 |
| Price To Earnings Diluted Growth Ratio | -18.555 | ▼-18.048 | ▼-12.082 |
| Price To Book Ratio | 1.747 | ▼-0.121 | ▼-1.262 |
| Price To Sales Ratio | 0.238 | ▼-0.022 | ▼-0.250 |
| Price To Free Cash Flow Ratio | 82.272 | ▲69.478 | ▲42.718 |
| Price To Operating Cash Flow Ratio | 33.498 | ▲23.185 | ▲13.786 |
| Debt To Assets Ratio | 0.265 | ▲0.001 | ▼-0.006 |
| Debt To Equity Ratio | 0.733 | ▼-0.016 | ▼-0.033 |
| Debt To Capital Ratio | 0.423 | ▼-0.005 | ▼-0.011 |
| Long Term Debt To Capital Ratio | 0.412 | ▲0.007 | ▲0.018 |
| Financial Leverage Ratio | 2.761 | ▼-0.067 | ▼-0.061 |
| Working Capital Turnover Ratio | -28.262 | ▼-7.860 | ▼-6.718 |
| Operating Cash Flow Ratio | 0.089 | ▼-0.174 | ▼-0.170 |
| Operating Cash Flow Sales Ratio | 0.007 | ▼-0.018 | ▼-0.022 |
| Free Cash Flow Operating Cash Flow Ratio | 0.407 | ▼-0.399 | ▼-0.217 |
| Debt Service Coverage Ratio | 3.403 | ▲1.350 | ▲1.316 |
| Interest Coverage Ratio | 2.303 | ▼-0.163 | ▼-3.873 |
| Short Term Operating Cash Flow Coverage Ratio | 6.140 | ▲2.043 | ▲2.982 |
| Operating Cash Flow Coverage Ratio | 0.071 | ▼-0.171 | ▼-0.169 |
| Capital Expenditure Coverage Ratio | 1.687 | ▼-3.471 | ▼-1.619 |
| Dividend Paid And Capex Coverage Ratio | 0.944 | ▼-2.005 | ▼-1.256 |
| Dividend Payout Ratio | 0.362 | ▲0.005 | ▲0.131 |
| Enterprise Value Multiple | 13.614 | ▲1.132 | ▼-0.413 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $30.85B | $30.59B | $56.71B | $64.75B | $59.69B | |
| Enterprise value | $39.59B | $40.63B | $64.28B | $71.44B | $69.52B | |
| EV / Sales | 0.30x | 0.34x | 0.60x | 0.77x | 0.83x | |
| EV / Op. cash flow | 42.98x | 13.70x | 16.15x | 15.57x | 30.74x | |
| EV / Free cash flow | 105.57x | 16.99x | 21.59x | 20.71x | 75.57x | |
| EV / EBITDA | 13.61x | 12.48x | 13.59x | 14.85x | 15.60x | |
| Net debt / EBITDA | 3.00x | 3.08x | 1.60x | 1.39x | 2.21x | |
| Current ratio | 0.72x | 0.44x | 0.56x | 0.58x | 0.50x | |
| Income quality | 0.77x | 2.44x | 1.60x | 1.64x | 0.77x | |
| Graham number | $180 | $175 | $244 | $246 | $253 | |
| Graham net-net | -$202 | -$212 | -$197 | -$174 | -$186 | |
| Tax burden | 81.8% | 74.2% | 75.0% | 78.7% | 85.8% | |
| Interest burden | 69.7% | 71.1% | 87.1% | 89.9% | 91.3% | |
| Working capital | -$2.84B | -$6.33B | -$5.22B | -$4.90B | -$5.29B | |
| Invested capital | $10.69B | $7.72B | $9.57B | $9.75B | $12.20B | |
| Return on assets | 2.4% | 2.6% | 5.3% | 6.4% | 6.6% | |
| Operating ROA | 3.1% | 3.5% | 7.3% | 8.1% | 8.6% | |
| Return on tangible assets | 3.1% | 3.4% | 7.0% | 8.6% | 9.5% | |
| Return on equity | 6.7% | 7.4% | 15.3% | 18.3% | 18.2% | |
| Return on invested capital | 3.1% | 3.4% | 6.8% | 8.2% | 8.1% | |
| Return on capital employed | 3.8% | 4.6% | 9.5% | 11.1% | 10.0% | |
| Earnings yield | 3.9% | 3.9% | 4.4% | 4.3% | 4.9% | |
| Free cash flow yield | 1.2% | 7.8% | 5.2% | 5.3% | 1.5% | |
| Capex / Op. cash flow | 59.3% | 19.4% | 25.2% | 24.8% | 59.3% | |
| Capex / Depreciation | 66.3% | 59.4% | 109.5% | 134.6% | 188.2% | |
| Capex / Sales | 0.4% | 0.5% | 0.9% | 1.2% | 1.6% | |
| SG&A / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | |
| Intangibles / Total assets | 22.2% | 23.9% | 24.0% | 24.9% | 30.7% | |
| Days sales outstanding | 9d | 8d | 7d | 7d | 8d | |
| Days payables outstanding | 32d | 37d | 42d | 44d | 43d | |
| Operating cycle | 9d | 8d | 7d | 7d | 8d | |
| Cash conversion cycle | -23d | -29d | -35d | -37d | -35d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-10-05 UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure UnitedHealth is exiting select Medicare Advantage plans for 2027 as rising medical costs pressure profitability, reshaping its membership mix.
- 2026-10-01 Humana Reports Third-Quarter Earnings Nov. 6, in the Middle of Open Enrollment. Members Got Their Plan-Change Letters Weeks Earlier. Wall Street Got the Numbers in July Humana already told investors in July how many members it plans to drop. What your neighbor with a surviving plan has not figured out yet is how quietly the costs on that plan changed before open enrollment closes Dec. 7.
- 2026-09-28 Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Sept. 28, 2026Shareholders are encouraged to contact the firm to dis
- 2026-09-28 Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
- 2026-09-25 Humana Jumps 7% on Barclays Upgrade and $515 Target; UnitedHealth Nudges Higher Barclays just pulled Humana off its neutral bench and handed it a bold new target, sending shares soaring while the rest of managed care barely blinked.
- 2026-09-18 Corient Private Wealth LP Cuts Stake in Humana Inc. $HUM Corient Private Wealth LP lowered its stake in shares of Humana Inc. (NYSE: HUM) by 15.3% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,114 shares of the insurance provider''s stock after selling 3,454 shares during the period.
- 2026-09-17 New Humana research finds association between pharmacy care coordination services and improved health outcomes for cancer patients LOUISVILLE, Ky.--(BUSINESS WIRE)--A new research study finds an association between pharmacy care coordination services and improved health outcomes for cancer patients.
- 2026-09-17 Bank of America Corp DE Invests $279.49 Million in Humana Inc. $HUM Bank of America Corp DE acquired a new stake in shares of Humana Inc. (NYSE: HUM) during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 703,615 shares of the insurance provider''s stock, valued at approximately $279,490,000. Bank of America Corp DE owned
- 2026-09-16 Humana Community Day 2026 Generates 2.2 Million Meals and Community Investments Nationwide Humana Inc. (NYSE: HUM) today announced the results of Humana Community Day 2026, the company''s annual nationwide day of service. In its third year, Humana Comm
- 2026-09-16 Humana Community Day 2026 Generates 2.2 Million Meals and Community Investments Nationwide LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced the results of Humana Community Day 2026, the company''s annual nationwide day of service. In its third year, Humana Community Day mobilized more than 18,000 employees across 28 states and Puerto Rico, supported 1,200 nonprofit organizations, and positively impacted 2.25 million lives and community members through volunteer projects focused on food security, neighborhood revitalization, environmental stewardship and social.